Thomas W. LeBlanc, MD, MA, MHS, FAAHPM, FASCO

Thomas W. LeBlanc, MD, MA, MHS, FAAHPM, FASCO

Duke University

H-index: 45

North America-United States

About Thomas W. LeBlanc, MD, MA, MHS, FAAHPM, FASCO

Thomas W. LeBlanc, MD, MA, MHS, FAAHPM, FASCO, With an exceptional h-index of 45 and a recent h-index of 38 (since 2020), a distinguished researcher at Duke University, specializes in the field of Hematologic oncology, palliative medicine, patient experience research, prognostication and patient understanding, communication.

His recent articles reflect a diverse array of research interests and contributions to the field:

Knowledge of Palliative Care and Barriers to Access Among Outpatients with Cancer

Work absenteeism, disability, and lost wages among patients with acute myeloid leukemia and their caregivers: a cohort study using US administrative claims and productivity data

443 Treatment experience and symptom burden in multiple myeloma: interim results of a longitudinal electronic patient-reported outcomes study

Oncologist in my Pocket: What the Palliative Clinician Needs to Know About Hematology, Oncology and Radiation Oncology

Overcoming transfusion needs as a barrier to hospice care for patients with blood cancers

A matching-adjusted indirect comparison of the efficacy of elranatamab versus teclistamab in patients with triple-class exposed/refractory multiple myeloma

Coping in patients with hematologic malignancies undergoing hematopoietic cell transplantation

Pain, substance use, and opioid prescribing in a prospective cohort with advanced cancer (GP138)

Thomas W. LeBlanc, MD, MA, MHS, FAAHPM, FASCO Information

University

Position

Associate Professor of Medicine Division of Hematologic Malignancies and Cellular Therapy

Citations(all)

8453

Citations(since 2020)

6614

Cited By

4155

hIndex(all)

45

hIndex(since 2020)

38

i10Index(all)

128

i10Index(since 2020)

114

Email

University Profile Page

Duke University

Google Scholar

View Google Scholar Profile

Thomas W. LeBlanc, MD, MA, MHS, FAAHPM, FASCO Skills & Research Interests

Hematologic oncology

palliative medicine

patient experience research

prognostication and patient understanding

communication

Top articles of Thomas W. LeBlanc, MD, MA, MHS, FAAHPM, FASCO

Title

Journal

Author(s)

Publication Date

Knowledge of Palliative Care and Barriers to Access Among Outpatients with Cancer

Journal of Pain and Symptom Management

Lindsay M Schlichte

Jordan Hildenbrand

Steven Wolf

Kris W Herring

Jesse D Troy

...

2024/2/1

Work absenteeism, disability, and lost wages among patients with acute myeloid leukemia and their caregivers: a cohort study using US administrative claims and productivity data

EXPERT REVIEW OF PHARMACOECONOMICS & OUTCOMES RESEARCH

Bhavik J Pandya

Christopher Young

Elizabeth R Packnett

Bin Xie

Timothy Lillehaugen

...

2024/2/26

443 Treatment experience and symptom burden in multiple myeloma: interim results of a longitudinal electronic patient-reported outcomes study

Journal of Clinical and Translational Science

Mihir Patel

Anneli Nina

Brenda Branchaud

David Campbell

Kris Herring

...

2024/4

Oncologist in my Pocket: What the Palliative Clinician Needs to Know About Hematology, Oncology and Radiation Oncology

Journal of Pain and Symptom Management

Kristina Newport

Shanthi Sivendran

Thomas W Leblanc

Joshua A Jones

2024/5/1

Overcoming transfusion needs as a barrier to hospice care for patients with blood cancers

Journal of Pain and Symptom Management

Matthew J Pisarcik

Thomas W LeBlanc

2024/1/1

A matching-adjusted indirect comparison of the efficacy of elranatamab versus teclistamab in patients with triple-class exposed/refractory multiple myeloma

Leukemia & Lymphoma

Isha Mol

Yannan Hu

Thomas W LeBlanc

Joseph C Cappelleri

Haitao Chu

...

2024/2/12

Coping in patients with hematologic malignancies undergoing hematopoietic cell transplantation

Blood Advances

Richard Newcomb

Hermioni L Amonoo

Ashley M Nelson

Joanna Choe

Katherine Holmbeck

...

2024/3/26

Pain, substance use, and opioid prescribing in a prospective cohort with advanced cancer (GP138)

Journal of Pain and Symptom Management

Katie Fitzgerald Jones

Paula Escott

Gretchen E White

Antonia V Bennett

Hailey Bulls

...

2024/5/1

Elranatamab efficacy in MagnetisMM-3 compared with real-world control arms in triple-class refractory multiple myeloma

Future Oncology

Luciano J Costa

Thomas W LeBlanc

Hans Tesch

Pieter Sonneveld

Ryan P Kyle

...

2024/2

Palliative and End-of-Life Care in Hematologic Malignancies: Progress and Opportunities.

JCO Oncology Practice

Mazie Tsang

Thomas W LeBlanc

2024/3/13

Facets of Physical Function Assessed by Patient-reported outcome measures in oncology research

Quality of Life Research

Theresa Coles

Rebecca Fillipo

Kate Plyler

Alexy Hernandez

Debra M Henke

...

2024/4/20

Effects of Palliative Care on Quality of Life and Psychological Distress of Patients Undergoing Hematopoietic Stem Cell Transplantation (HSCT) and Their Caregivers

Transplantation and Cellular Therapy

Areej R El-Jawahri

Thomas LeBlanc

Ali Rhodes Kavanaugh

Jason A Webb

James Fausto

...

2024/2/1

Benefits, Harms, and Stakeholder Perspectives Regarding Opioid Therapy for Pain in Individuals With Metastatic Cancer: Protocol for a Descriptive Cohort Study

JMIR Research Protocols

Katie Fitzgerald Jones

Gretchen White

Antonia Bennett

Hailey Bulls

Paula Escott

...

2024/3/13

Impact of AML on patient and caregiver workplace absenceWork absenteeism, disability, and lost wages among patients with acute myeloid leukemia and caregivers: a cohort study …

Bhavik J Pandya

Christopher Young

Elizabeth R Packnett

Bin Xie

Timothy Lillehaugen

...

2024/4/20

Relationships between Sociodemographic Factors and Fatigue Prior to Hematopoietic Cell Transplantation

Transplantation and Cellular Therapy

Ashley M Nelson

Ally M Wood

Joseph A Greer

Thomas LeBlanc

Stephanie J Lee

...

2024/2/1

Protocol for multi-site randomized trial of inpatient palliative care for patients with hematologic malignancies undergoing hematopoietic stem cell transplantation

Contemporary Clinical Trials

Daniel Yang

Richard Newcomb

Alison R Kavanaugh

Dania Khalil

Joseph A Greer

...

2024/3/1

Mindful Night-to-Day: A Pilot Feasibility Trial of a Mindfulness-Based Insomnia and Symptom Management Intervention for Patients with Hematologic Cancer

Behavioral Sleep Medicine

Hannah M Fisher

Kelly A Hyland

Shannon N Miller

Grace H Amaden

Allison Diachina

...

2024/4/11

Patient perspectives on considerations, tradeoffs, and experiences with multiple myeloma treatment selection: a qualitative descriptive study

BMC cancer

Carrie Dombeck

Teresa Swezey

Juan Marcos Gonzalez Sepulveda

Bryce B Reeve

Thomas W LeBlanc

...

2023/1/19

Novel agents and regimens in acute myeloid leukemia: latest updates from 2022 ASH Annual Meeting

Journal of Hematology & Oncology

Katherine W DiNardo

Thomas W LeBlanc

Hui Chen

2023/3/3

Isavuconazonium or posaconazole for antifungal prophylaxis in patients with acute myeloid leukemia

Journal of Oncology Pharmacy Practice

Olivia White

Erin Kennedy

Jordan B Huckabee

Elizabeth Rogers

Thomas W LeBlanc

...

2023/5/15

See List of Professors in Thomas W. LeBlanc, MD, MA, MHS, FAAHPM, FASCO University(Duke University)

Co-Authors

H-index: 98
Peter Ubel

Peter Ubel

Duke University

H-index: 88
David Christopher Currow

David Christopher Currow

University of Technology Sydney

H-index: 69
Anthony Back

Anthony Back

University of Washington

academic-engine